drugset / Trial / NCT02376049

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

NCT02376049

Phase 1 Completed 30 enrolled LEO Pharma
RandomizedSingle-groupDouble-blindTreatment

Summary

An Explorative Clinical Trial to Evaluate an Intra Patient Comparison Design of Topical Agents in Adults with Mild to Moderate Atopic Dermatitis.

Timeline

Start
2015-02
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pimecrolimus Small molecule 1 % Topical
Comparator betamethasone dipropionate Small molecule 0.05 % Topical
Comparator clobetasol propionate Small molecule 0.05 % Topical

Indications